95 related articles for article (PubMed ID: 27273463)
21. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
22. Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome.
Robles JD; Cheuk DK; Ha SY; Chiang AK; Chan GC
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1883-9. PubMed ID: 22796532
[TBL] [Abstract][Full Text] [Related]
23. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
24. Human herpesvirus types 6 and 7 infection in pediatric hematopoietic stem cell transplant recipients.
Fule Robles JD; Cheuk DK; Ha SY; Chiang AK; Chan GC
Ann Transplant; 2014 Jun; 19():269-76. PubMed ID: 24881673
[TBL] [Abstract][Full Text] [Related]
25. [Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation].
Xu HG; Fang JP; Huang SL; Zhou DH; Chen C; Huang K; Li Y
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):126-30. PubMed ID: 16624030
[TBL] [Abstract][Full Text] [Related]
26. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients.
Mullen CA; Nair J; Sandesh S; Chan KW
Bone Marrow Transplant; 2000 Jan; 25(1):59-65. PubMed ID: 10654016
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan.
Amayiri N; Al-Zaben A; Ghatasheh L; Frangoul H; Hussein AA
Pediatr Transplant; 2013 Jun; 17(4):394-402. PubMed ID: 23692601
[TBL] [Abstract][Full Text] [Related]
28. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
29. Infections in children with cancer: a continued need for the comprehensive physical examination.
Auletta JJ; O'Riordan MA; Nieder ML
J Pediatr Hematol Oncol; 1999; 21(6):501-8. PubMed ID: 10598661
[TBL] [Abstract][Full Text] [Related]
30. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
[TBL] [Abstract][Full Text] [Related]
31. [A clinical study of rhG-CSF in accelerating hematological recovery following autologous hematopoietic stem cells transplantation].
Yang JL; Shi YK; He XH; Zhou SY; Zhou AP; Han XH; Liu P; Zhang CG; Ai B
Ai Zheng; 2003 Aug; 22(8):785-9. PubMed ID: 12917020
[TBL] [Abstract][Full Text] [Related]
32. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
[TBL] [Abstract][Full Text] [Related]
33. Infection surveillance in pediatric hematopoietic stem cell transplantation recipients.
Caldas Teixeira D; Martins Oliveira Diniz L; Orlandi Mourão PH; Kakehashi FM; Vaz de Macedo A; Duani H; Trindade Clemente W; de Sá Rodrigues KE; Maia de Castro Romanelli R
Eur J Haematol; 2018 Jan; 100(1):69-74. PubMed ID: 29032585
[TBL] [Abstract][Full Text] [Related]
34. Infections during mobilizing chemotherapy and following autologous stem cell transplantation.
Toor AA; van Burik JA; Weisdorf DJ
Bone Marrow Transplant; 2001 Dec; 28(12):1129-34. PubMed ID: 11803354
[TBL] [Abstract][Full Text] [Related]
35. Improved outcomes for stem cell transplant recipients requiring pediatric intensive care.
Chima RS; Daniels RC; Kim MO; Li D; Wheeler DS; Davies SM; Jodele S
Pediatr Crit Care Med; 2012 Nov; 13(6):e336-42. PubMed ID: 22791094
[TBL] [Abstract][Full Text] [Related]
36. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
Hori A; Kami M; Kim SW; Chizuka A; Kojima R; Imataki O; Sakiyama M; Hamaki T; Onishi Y; Usubuchi N; Kishi Y; Murashige N; Tajima K; Miyakoshi S; Heike Y; Masuo S; Taniguchi S; Takaue Y
Biol Blood Marrow Transplant; 2004 Jan; 10(1):65-72. PubMed ID: 14752781
[TBL] [Abstract][Full Text] [Related]
37. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors.
Reich G; Mapara MY; Reichardt P; Dörken B; Maschmeyer G
Bone Marrow Transplant; 2001 Mar; 27(5):525-9. PubMed ID: 11313687
[TBL] [Abstract][Full Text] [Related]
38. Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning.
Jaime-Pérez JC; Villarreal-Villarreal CD; Salazar-Riojas R; Méndez-Ramírez N; Vázquez-Garza E; Gómez-Almaguer D
Biol Blood Marrow Transplant; 2015 Mar; 21(3):526-30. PubMed ID: 25498924
[TBL] [Abstract][Full Text] [Related]
39. Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.
Taimur S; Nader C; Lloyd-Travaglini C; Seldin DC; Sanchorawala V
Transpl Infect Dis; 2013 Apr; 15(2):187-94. PubMed ID: 23279695
[TBL] [Abstract][Full Text] [Related]
40. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
